BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6752115)

  • 21. Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria.
    Dale JW
    Biochem J; 1971 Jul; 123(4):501-5. PubMed ID: 4942447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.
    Lindberg F; Normark S
    Rev Infect Dis; 1986; 8 Suppl 3():S292-304. PubMed ID: 3529322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxonomic investigations on expressed and cryptic phospho-beta-glucosidases in Enterobacteriaceae.
    Schaefler S; Malamy A
    J Bacteriol; 1969 Aug; 99(2):422-33. PubMed ID: 4897109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-lactamase production in Enterobacter cloacae and Citrobacter freundii.
    Søgaard P
    Acta Pathol Microbiol Immunol Scand B; 1984 Dec; 92(6):319-24. PubMed ID: 6335817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thin-layer chromatographic technique for rapid detection of bacterial phospholipases.
    Legakis NJ; Papavassiliou J
    J Clin Microbiol; 1975 Nov; 2(5):373-6. PubMed ID: 811682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.
    Kim J; Lim YM
    J Clin Microbiol; 2005 May; 43(5):2452-5. PubMed ID: 15872281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.
    Sanguinetti M; Posteraro B; Spanu T; Ciccaglione D; Romano L; Fiori B; Nicoletti G; Zanetti S; Fadda G
    J Clin Microbiol; 2003 Apr; 41(4):1463-8. PubMed ID: 12682131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
    Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
    J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 5'-nucleotidases (uridine diphosphate sugar hydrolases) of the Enterobacteriaceae.
    Neu HC
    Biochemistry; 1968 Oct; 7(10):3766-73. PubMed ID: 4878706
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of Vitek 2 performance for identifying extended spectrum beta-lactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp"].
    Diamante P; Camporese A
    Infez Med; 2006 Dec; 14(4):216-26. PubMed ID: 17380089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the kinetic interaction between ceftriaxone and some beta-lactamases.
    Amicosante G; Maccarrone M; Franceschini N; Oliva B; Segatore B; Oratore A
    Drugs Exp Clin Res; 1988; 14(1):25-30. PubMed ID: 3260552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effect of YTR (tazobactam) on plasmid and chromosomally mediated beta-lactamases.
    Stobberingh EE
    Chemotherapy; 1990; 36(3):209-14. PubMed ID: 2159864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in beta-lactam resistance among Enterobacteriaceae.
    Nordmann P
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S100-6. PubMed ID: 9710678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and sequencing of the beta-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus.
    Naas T; Aubert D; Fortineau N; Nordmann P
    FEMS Microbiol Lett; 2002 Sep; 215(1):81-7. PubMed ID: 12393205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamases.
    Pitout JD; Reisbig MD; Venter EC; Church DL; Hanson ND
    J Clin Microbiol; 2003 Aug; 41(8):3933-5. PubMed ID: 12904422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
    Tzouvelekis LS; Prinarakis EE; Gazouli M; Miriagou V; Tzelepi E; Legakis NJ
    Chemotherapy; 1996; 42(5):324-8. PubMed ID: 8874970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypsin peptide patterns of tryptophan synthase beta2 protein among four species of the Enterobacteriaceae.
    Brennan EF; Rocha V
    J Bacteriol; 1978 Nov; 136(2):790-4. PubMed ID: 361723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
    Jeong SH; Song W; Park MJ; Kim JS; Kim HS; Bae IK; Lee KM
    Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminopeptidase I activities in several microorganisms.
    DeMarco AC; Dick AJ
    Can J Biochem; 1978 Jan; 56(1):66-71. PubMed ID: 110425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.